N-Dodecanoyl-NBD-D-erythro-sphingosine惠诚

H1625

N-Dodecanoyl-NBD-D-erythro-dihydrosphingosine

synthetic

C₃₆H₆₃N₅O₆

662

100ug

solid

98+% TLC

N-C12:0-NBD-Dihydroceramide; N-C12:0-NBD-D-erythro-Dihydrosphingosine

methanol, chloroform/methanol, 2:1

-20°C

1. J. Kok et al. “Dihydroceramide Biology STRUCTURE-SPECIFIC metaBOLISM AND INTRACELLULAR LOCALIZATION” Journal of Biological Chemistry, Vol. 272 pp. 21128-21136, 1997
2. J. Hsu et al. “Enhanced endothelial delivery and biochemical effects of
-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease” Journal of Controlled Release, doi:10.1016/j.jconrel.2010.10.031, 2010
3. W. Zheng “Fenretinide increases dihydroceramide and dihydrosphingolipids due to inhibition of dihydroceramide desaturase” Georgia Institute of Technology, 2006